AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Survey shows demand high for needle-free, intranasal flu vaccine.(Brief Article)

Vaccine Weekly

| November 13, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 NOV 13 - (NewsRx.com & NewsRx.net) -- According to a survey conducted by SG Cowen, there is strong demand among doctors for FluMist, a flu vaccine that is administered through the nose rather than by a shot in the arm.

The survey also concludes that patients would overwhelmingly prefer the intranasal vaccine.

Confirming that patients don't like shots, the survey found that 78% of patients would prefer an intranasal vaccine versus an intramuscular vaccine, and that physicians would use FluMist in over 50% of flu vaccinations.

Additional FluMist survey findings include:

* 90% of physicians would prescribe a live attenuated intranasal vaccine instead of the traditional inactivated intramuscular flu vaccine.

* Pricing is a key issue: the survey suggests most patients will ...

Related articles from newspapers, magazines, journals, and more
Sales soar: Scare revives FluMist health.(News)
Magazine article from: Advertising Age Thomaselli, Rich December 15, 2003 700+ words
...stances and decided to cover FluMist for the current flu season...increase in sales activity for FluMist but anecdotal evidence indicated...Philip Nadeau, an analyst with SG Cowen & Co., New York, expects...million to 3 million doses of FluMist to be sold in the coming weeks...
MEDIMMUNE 'WORKING FEVERISHLY' ON RESOLVING FLUMIST CONCERNS.
Magazine article from: BIOWORLD Today Huggett, Brady July 12, 2002 700+ words
...equity research at SG Cowen Securities Corp. He...months of review time. FluMist is designed to prevent...Werber's firm models FluMist's price at $30 per...the season after that. FluMist is partnered worldwide...following seasons, by SG Cowen's model. MedImmune...
MedImmune Working Feverishly' On Resolving FluMist Concerns.
Magazine article from: BIOWORLD Today November 4, 2009 700+ words
...equity research at SG Cowen Securities Corp. He...months of review time. FluMist is designed to prevent...Werber's firm models FluMist's price at $30 per...the season after that. FluMist is partnered worldwide...following seasons, by SG Cowen's model. MedImmune...
AVIRON'S FLUMIST BLA DELAYED FOLLOWING VALIDATION PROBLEMS.
Magazine article from: BIOWORLD Today Welch, Mary November 16, 1999 700+ words
...which made some components of FluMist, received a warning letter...manufactured in a different room than FluMist components, it is unclear...Schmidt, vice president of SG Cowen Securities Corp. in Boston...be capable of manufacturing FluMist to required specifications...
FluMist to be donated to public health agencies.
Newspaper article from: Pharma Business Week February 9, 2004 700+ words
...flu vaccine, the sellers of FluMist say that they plan to donate...proof of how poor sales of FluMist are, even during one of the...Philip Nadeau, an analyst with SG Cowen Securities. State and local health agencies can order FluMist from Wyeth and MedImmune under...
MEDIMMUNE EXPECTS TO TAKE FLUMIST BACK TO PANEL THIS YEAR.(Food and Drug...
Magazine article from: BIOWORLD Today Coghill, Kim October 28, 2002 700+ words
...sure if I can characterize FluMist as a setback because I think...Unresolved issues surrounding FluMist are asthma, concurrent use...pneumonia, the transmission of FluMist's attenuated virus between...Nadeau, an analyst with SG Cowen.
MedImmune 'working feverishly' to resolve FluMist concerns.
Newspaper article from: Medical Device Daily July 15, 2002 700+ words
...originally filed its BLA for FluMist in October 2000. An FDA advisory...not to recommend approval for FluMist in July 2001, asking for more...biotechnology, equity research at SG Cowen Securities. He added that...for the season after that. FluMist is partnered worldwide with...
MedImmune stock rallies on sales of FluMist vaccine.(BUSINESS)(YOUR MONEY:...
Newspaper article from: The Washington Times October 7, 2003 700+ words
...for FluMist. He argued that FluMist, which is twice as expensive...will pay higher prices for FluMist," Mr. West said, advising...Nadeau, a biotech analyst at SG Cowen Securities Corp., projected...32.78. "Indicators show FluMist is going to be a good product...
For more facts and information, see all results

Source: HighBeam Research, Survey shows demand high for needle-free, intranasal flu...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA